| ID | Sequence | Length | GC content |
|---|---|---|---|
| GUGCUUGUAGUCCCAGACACUCCGGAGGUGAGGCGGGAGAAUCGCUUGA… | 1002 nt | 0.4770 | |
| GCGUCUUGUUCUUGCCUGGUGUCGGUGGUUAGUUUCUGCGACUUGUGUU… | 1165 nt | 0.5107 | |
| GCGUCUUGUUCUUGCCUGGUGUCGGUGGUUAGUUUCUGCGACUUGUGUU… | 1139 nt | 0.5083 | |
| GCGUCUUGUUCUUGCCUGGUGUCGGUGGUUAGUUUCUGCGACUUGUGUU… | 945 nt | 0.4624 |
This gene encodes a member of the peroxiredoxin family of antioxidant enzymes, which reduce hydrogen peroxide and alkyl hydroperoxides. The encoded protein may play an antioxidant protective role in cells, and may contribute to the antiviral activity of CD8(+) T-cells. This protein may have a proliferative effect and play a role in cancer development or progression. Four transcript variants encoding the same protein have been identified for this gene. [provided by RefSeq, Jan 2011]
A study in humans and mice demonstrated that peroxiredoxin-1 (PRDX1) was identified as a differentially expressed protein present in serum exosomes from septic patients but not in healthy individuals [Li et al. DOI:10.1016/j.jare.2021.11.005]. A study in mice demonstrated that chronic methamphetamine administration significantly dysregulated transcription factors in cortical glial cells, with Zbtb16, Hif3a, Foxo1, and Klf9 being notably altered across astrocytes, microglia, and oligodendrocytes [Oladapo et al. DOI:10.3390/Ijms26020649].